Active, Not Recruiting
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
NCT04990726
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Melanoma Stage IV, +17 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States